Türk Nöroloji Dergisi (Jun 2010)
Primary and Secondary Intracranial Hypotension: Clinical, MRI and Radioisotope Cisternography Findings
Abstract
OBJECTIVE: It was aimed to evaluate the clinical features, magnetic resonance imaging (MRI) and radioisotope cisternography findings and results of the treatment in intracranial hypotension. METHODS: Fifteen patients diagnosed with intracranial hypotension were evaluated retrospectively. The opening pressure and analysis of cerebrospinal fluid (CSF), cerebral and spinal MRI and radioisotope cisternography findings, clinical features, and results of the treatment are discussed. RESULTS: The mean age of 15 patients, 11 women and 4 men, was 37 years. Eleven patients had spontaneous (primary) and 4 had secondary intracranial hypotension. Fourteen (93.3%) patients had orthostatic headache, and 1 (6.6%) patient’s headache did not have a postural feature. In addition to the headache, 5 (33.3%) patients had nausea and vomiting, 1 patient had diplopia, 1 had neck pain, and 1 had vertigo. Cerebral MRI revealed dural thickening in 12 (85.7%) patients, enlarged hypophysis in 5 (35.7%) patients, brain sagging in 3 (21.4%) patients, subdural hematoma in 2 (14.2%) patients, and subdural effusion in 2 (14.2%) patients. Spinal MRI was normal in 5 (83.3%) of 6 patients, and it showed meningeal thickening in 1 (16.6%). Radioisotope cisternography revealed CSF leak in 8 (88.8%) of 9 patients. CSF opening pressure was ≤ 60 mmH2O in 8 (88.8%) of 9 patients. CSF protein was increased in 3 patients. Complete improvement was obtained with conservative treatment in 8 (53.3%) patients. Seven (46.6%) patients who did not improve with conservative treatment were administered epidural blood patching, and 6 of these 7 patients improved completely. CONCLUSION: Orthostatic headache, low CSF opening pressure and characteristic MRI findings are essential criteria for diagnosis of intracranial hypotension. Radioisotope cisternography is useful to detect CSF leak. In patients who do not improve with conservative treatment, autologous blood patch should be applied
